Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Structured Cardiovascular Risk Management.
- Who it may be relevant to
- Registry conditions: Cardiovascular Risk Factors, Hypertension, Dyslipidemia, Type 2 Diabetes Mellitus. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Chile
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of a Structured Clinical and Pharmacological Management Strategy on Cardiovascular Risk Factors in Adult Patients in Routine Clinical Practice: A Pseudo-Experimental Before-and-After Study
Overview
This study aims to evaluate cardiovascular risk factors, clinical characteristics, and outcomes in adult patients attending an outpatient cardiology clinic. The research focuses on identifying predictors of adverse cardiovascular events, optimizing risk stratification, and improving preventive strategies in routine clinical practice. Data will be collected from patients receiving standard cardiology care without altering their treatment. The results are expected to contribute to better understanding of cardiovascular risk profiles and to support improvements in clinical decision-making and patient management.
Interventions
- Other Structured Cardiovascular Risk Management
Protocol-based clinical management including periodic evaluation and adjustment of antihypertensive, lipid-lowering, antidiabetic, and lifestyle interventions according to routine clinical practice guidelines.
Primary outcome measures
- Change in systolic blood pressure [Time frame: Baseline to 90 days]
Secondary outcome measures (11)
- Change in diastolic blood pressure [Time frame: Baseline to 90 days]
- Change in LDL cholesterol [Time frame: Baseline to 90 days]
- Change in HbA1c [Time frame: Baseline to 90 days]
- Change in body weight [Time frame: Baseline to 90 days]
- Change in renal function (eGFR) [Time frame: Baseline to 90 days]
- Change in HDL cholesterol [Time frame: Baseline to 90 days]
- Change in triglycerides [Time frame: Baseline to 90 days]
- Change in total cholesterol [Time frame: Baseline to 90 days]
- Change in fasting plasma glucose [Time frame: Baseline to 90 days]
- Change in body mass index [Time frame: Baseline to 90 days]
- Change in microalbuminuria [Time frame: Baseline to 90 days]
Eligibility criteria
Inclusion criteria
- Age ≥18 years
- Presence of at least one cardiovascular risk factor (hypertension, diabetes, dyslipidemia, obesity, or smoking)
- Receiving outpatient clinical follow-up
- Ability to provide informed consent
Exclusion criteria
- Severe clinical instability requiring hospitalization
- Pregnancy
- End-stage renal disease or dialysis
- Inability to complete follow-up visits
- Refusal to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
Chile · 1 center
- CDIEM Medical Center - Outpatient Cardiology Clinic — Santiago
Identifiers
NCT: NCT07447362 · UCAM-CVRISK-2024